Lydia Meder

1.9k total citations
21 papers, 783 citations indexed

About

Lydia Meder is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lydia Meder has authored 21 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lydia Meder's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and RNA modifications and cancer (4 papers). Lydia Meder is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and RNA modifications and cancer (4 papers). Lydia Meder collaborates with scholars based in Germany, United States and Switzerland. Lydia Meder's co-authors include Lukas C. Heukamp, Mirjam Koker, Martin Peifer, Katharina König, Roman K. Thomas, Roland T. Ullrich, Reinhard Buettner, Jürgen Wolf, Florian Malchers and William Pao and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Lydia Meder

18 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lydia Meder Germany 13 408 395 311 198 121 21 783
Elisabetta Zulato Italy 16 342 0.8× 600 1.5× 266 0.9× 492 2.5× 63 0.5× 37 1.0k
Daniela Morales-Espinosa Spain 12 276 0.7× 206 0.5× 190 0.6× 155 0.8× 72 0.6× 25 534
Gloria Manzotti Italy 14 221 0.5× 612 1.5× 124 0.4× 255 1.3× 162 1.3× 31 918
Toshio Fujino Japan 16 420 1.0× 402 1.0× 563 1.8× 142 0.7× 58 0.5× 54 975
Francesca Simionato Italy 17 455 1.1× 290 0.7× 199 0.6× 199 1.0× 49 0.4× 31 794
Pietro De Placido Italy 13 488 1.2× 245 0.6× 396 1.3× 225 1.1× 60 0.5× 53 816
Dianyun Ren China 16 261 0.6× 419 1.1× 141 0.5× 202 1.0× 51 0.4× 25 708
Jih‐Hsiang Lee Taiwan 19 669 1.6× 347 0.9× 561 1.8× 196 1.0× 98 0.8× 37 1.0k
Pinzhu Huang China 18 270 0.7× 513 1.3× 122 0.4× 289 1.5× 198 1.6× 50 978

Countries citing papers authored by Lydia Meder

Since Specialization
Citations

This map shows the geographic impact of Lydia Meder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Meder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Meder more than expected).

Fields of papers citing papers by Lydia Meder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lydia Meder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Meder. The network helps show where Lydia Meder may publish in the future.

Co-authorship network of co-authors of Lydia Meder

This figure shows the co-authorship network connecting the top 25 collaborators of Lydia Meder. A scholar is included among the top collaborators of Lydia Meder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lydia Meder. Lydia Meder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weng, Jialei, Feng Ju, Ningbo Fan, et al.. (2025). Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers. Journal of Experimental & Clinical Cancer Research. 44(1). 314–314.
2.
Zhao, Xinlei, Ivo Kocák, Qian Yang, et al.. (2025). TAT-CRE inhalation enables tumor induction corresponding to adenoviral Cre-recombinase in a lung cancer mouse model. Communications Biology. 8(1). 741–741.
3.
Yu, Xiaojie, et al.. (2022). SQSTM1/p62 promotes miR-198 loading into extracellular vesicles and its autophagy-related secretion. Human Cell. 35(6). 1766–1784. 5 indexed citations
4.
Borchmann, Sven, Margarete Odenthal, Alexandra Florin, et al.. (2022). EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer. Cancers. 14(16). 3943–3943. 14 indexed citations
5.
Meder, Lydia, Florian Gebauer, Roland T. Ullrich, et al.. (2022). Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus. Cancers. 14(19). 4789–4789. 11 indexed citations
6.
Hussong, Michelle, Jörg Isensee, Christina Grimm, et al.. (2021). Pericentromeric Satellite III transcripts induce etoposide resistance. Cell Death and Disease. 12(6). 530–530. 12 indexed citations
7.
Meder, Lydia, Alexandra Florin, Luka Ozretić, et al.. (2021). Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous KrasLSL-G12V Driven Lung Cancer Mouse Model. Pathology & Oncology Research. 27. 596522–596522. 3 indexed citations
8.
Mittenbühler, Melanie J., Hendrik Nolte, Lara Kern, et al.. (2020). Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo. Molecular Metabolism. 42. 101085–101085. 42 indexed citations
9.
Borchmann, Sven, Helen Goergen, Lydia Meder, et al.. (2019). Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma. Journal of Clinical Oncology. 37(36). 3528–3537. 22 indexed citations
10.
Meder, Lydia, Katharina König, Felix Dietlein, et al.. (2018). LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model. Oncogene. 37(20). 2746–2756. 18 indexed citations
11.
Meder, Lydia, Mirjam Koker, Sven Borchmann, et al.. (2018). Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer. Oncogene. 37(42). 5682–5693. 31 indexed citations
12.
Dalvi, Priya, Soyoung Lim, Lydia Meder, et al.. (2018). Preclinical studies reveal that LSD1 inhibition results in tumor growth arrest in lung adenocarcinoma independently of driver mutations. Molecular Oncology. 12(11). 1965–1979. 27 indexed citations
13.
Tiedje, Vera, Katharina König, Saskia Ting, et al.. (2016). Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. Endocrine. 54(3). 733–741. 44 indexed citations
14.
Meder, Lydia & Reinhard Buettner. (2016). Elucidating alternative pathways triggering small cell lung carcinoma tumor biology. Translational Cancer Research. 5(S2). S363–S365. 1 indexed citations
15.
Meder, Lydia, Katharina König, Luka Ozretić, et al.. (2015). NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. International Journal of Cancer. 138(4). 927–938. 141 indexed citations
16.
Meder, Lydia, Katharina König, Jana Fassunke, et al.. (2015). Implementing amplicon-based next generation sequencing in the diagnosis of small cell lung carcinoma metastases. Experimental and Molecular Pathology. 99(3). 682–686. 8 indexed citations
17.
Chatterjee, Sampurna, Lukas C. Heukamp, Jakob Schöttle, et al.. (2013). Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation. 123(4). 1732–1740. 164 indexed citations
18.
König, Katharina, Lydia Meder, Cornelia Kröger, et al.. (2013). Loss of the Keratin Cytoskeleton Is Not Sufficient to Induce Epithelial Mesenchymal Transition in a Novel KRAS Driven Sporadic Lung Cancer Mouse Model. PLoS ONE. 8(3). e57996–e57996. 24 indexed citations
19.
Chatterjee, Sampurna, Lukas C. Heukamp, Jakob Schöttle, et al.. (2013). Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation. 123(7). 3183–3183. 15 indexed citations
20.
Heuckmann, Johannes M., Hyatt Balke‐Want, Florian Malchers, et al.. (2012). Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants. Clinical Cancer Research. 18(17). 4682–4690. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabetta Zulato Breakdown of academic impact, for papers by Daniela Morales-Espinosa Breakdown of academic impact, for papers by Gloria Manzotti Breakdown of academic impact, for papers by Toshio Fujino Breakdown of academic impact, for papers by Francesca Simionato Breakdown of academic impact, for papers by Pietro De Placido Breakdown of academic impact, for papers by Dianyun Ren Breakdown of academic impact, for papers by Jih‐Hsiang Lee Breakdown of academic impact, for papers by Pinzhu Huang
Rankless by CCL
2026